| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCAPI1024 | Cefditoren pivoxil | Cefditoren pivoxil |
|
| DC8686 | Cefetamet pivoxil hydrochloride | Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic. |
|
| DC9358 | Cefmenoxime (hydrochloride) | Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic. |
|
| DCAPI1038 | Cefoselis sulfate | Cefoselis sulfate |
|
| DC20190 | Cefoxitin | Cefoxitin is a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. |
|
| DC8067 | Cefozopran Featured | Cefozopran (SCE-2787) is a new parenteral cephalosporin, against experimental infections in mice. |
|
| DC9356 | Cefpiramide (sodium) | Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. |
|
| DC8687 | Cefpirome sulfate | Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. |
|
| DCAPI1033 | Cefprozil hydrate (Cefzil) | Cefprozil hydrate (Cefzil) |
|
| DC9355 | Ceftibuten (dihydrate) | Ceftibuten dihydrate is a third-generation cephalosporin antibiotic. |
|
| DC12245 | Ceftizoxime | Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan. |
|
| DCAPI1155 | Celastrol Featured | Celastrol is a potent proteasome inhibitor for the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. |
|
| DCAPI1491 | Celecoxib Featured | Celecoxib is a selective Cox-2 inhibitor (IC50 of 40 nM). Celecoxib shows low sensitivity against Cox-1 (IC50 of 15 μM). Celecoxib shows an anti-proliferative effect on nasopharyngeal carcinoma (NPC) cell lines including HNE1 (IC50of 32.86 μM) and CNE1-LM |
|
| DC7569 | Z-LEHD-FMK | Cell permeable fluoromethyl ketone (FMK)-derivatized peptides act as effective irreversible Caspase inhibitors with no cytotoxic effects and, therefore, are useful tools for studying Caspase activity. |
|
| DC7568 | Z-DEVD-FMK Featured | Cell-permeable, irreversible inhibitor of caspase-3/CPP32; inhibits tumor cell apoptosis. Neuroprotective in rat hippocampus following seizures in vivo. |
|
| DC9923 | CeMMEC1 Featured | CeMMEC1 is a novel potent inhibitor of the second bromodomain of TAF1, binding neither the first nor the second bromodomain of BRD4. |
|
| DC23359 | CeMMEC2 | CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM, binds to both bromodomains of BRD4, comparably to (S)-JQ1.. |
|
| DC10357 | Cenerimod | Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate 1 receptor (S1P1) agonist extracted from patent WO 2016184939 A1 and WO 2011007324 A1, example 1, with an EC50 of 2.7 nM. |
|
| DC10316 | Cenicriviroc Featured | Cenicriviroc is an orally active, dual CCR2/CCR5 antagonist, and displays potent anti-inflammatory and aninfective activity. |
|
| DC21554 | AS 703569 | Cenisertib (AS 703569;R763) is a novel potent, orally available inhibitor of Aurora kinases, exhibits signifficant anti-proliferative activity against a wide range of tumor cells both in vitro and in vivo (A549 EC50=9 nM). |
|
| DC12318 | Centanafadine hydrochloride (EB-1020 (hydrochloride)) | Centanafadine (hydrochloride) is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively. |
|
| DC12319 | Centanafadine (EB-1020) | Centanafadine is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively. |
|
| DC10010 | Centrinone Featured | Centrinone is a selective and reversible inhibitor of polo-like kinase 4 (Plk4), a serine-threonine protein kinase that initiates centriole/centrosome assembly. |
|
| DC22796 | CEP-1347 | CEP-1347 (KT-7515) is a potent and selective MLK inhibitor that completely rescues motoneurons and inhibits JNK1 activation with IC50 of 20 nM. |
|
| DC8138 | CEP-28122 Featured | CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. |
|
| DC8777 | CEP-32496 hydrochloride | CEP-32496 Hcl is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRβ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2. |
|
| DC8196 | CEP-32496 Featured | CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRβ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2. |
|
| DC7099 | CEP33779 Featured | CEP33779(< 3 μM) inhibits phosphorylation of downstream target signal transducer and activator of transcription 5(pSTAT5) of JAK2 in a concentration dependent manner in HEL92 cells. |
|
| DC8009 | CEP-37440 Featured | CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma). |
|
| DC10337 | CEP-40783 Featured | CEP-40783 is a potent, selective and orally available inhibitor of AXL and c-Met with IC50 values of 7 nM and 12 nM, respectively. |
|
